| GWAS |
- Aluminium levels ( 26025379
)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028
)
- Blood protein levels ( 30072576
)
- Metabolite levels ( 23823483
)
- Neurociticism ( 29500382
)
- Paclitaxel disposition in epithelial ovarian cancer ( 29367611
)
- Schizophrenia ( 25056061
29483656
)
|
- Asthma ( 31619474
)
- Body mass index ( 26426971
)
- Glycine levels ( 30837465
)
- HDL cholesterol ( 30275531
)
- HDL cholesterol levels ( 30698716
)
- HDL cholesterol levels in current drinkers ( 30698716
)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716
)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716
)
- Hip circumference adjusted for BMI ( 34021172
)
- LDL cholesterol levels ( 30698716
)
- LDL cholesterol levels in current drinkers ( 30698716
)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716
)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716
)
- Medication use (HMG CoA reductase inhibitors) ( 31015401
)
- Multiple sclerosis ( 22190364
)
- Optic cup area ( 25631615
)
- Simvastatin-induced myopathy ( 31220337
)
- Total cholesterol levels ( 33339817
)
- Triglyceride levels ( 30698716
)
- Triglyceride levels in current drinkers ( 30698716
)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716
)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716
)
- Very long-chain saturated fatty acid levels (fatty acid 20:0) ( 25378659
)
|
